HomeHealth Stocks

Health Stocks

Should Investors Consider Buying Pfizer Stock After a 32% Decline in a Year?

Should Investors Consider Buying Pfizer Stock After a 32% Decline in a Year?

April 5, 2024

Walgreens to Report Q2 Earnings: What to Expect

Walgreens to Report Q2 Earnings: What to Expect

March 21, 2024

Pfizer to Trim Ownership Stake in Haleon from 32% to 24%

Pfizer to Trim Ownership Stake in Haleon from 32% to 24%

March 19, 2024

Pfizer’s Adcetris Achieves Survival Goal in Lymphoma Study

Pfizer’s Adcetris Achieves Survival Goal in Lymphoma Study

March 13, 2024

3M’s Board Greenlights Spin-Off of Health Care Business

3M’s Board Greenlights Spin-Off of Health Care Business

March 11, 2024

Bristol Myers’ Krazati sNDA for CRC Receives Priority Review

Bristol Myers’ Krazati sNDA for CRC Receives Priority Review

February 21, 2024

Pfizer Stock Has Likely Already Bottomed

Pfizer Stock Has Likely Already Bottomed

February 14, 2023

Top Biopharm Stocks Today: Here’s What Investors Should Know

Top Biopharm Stocks Today: Here’s What Investors Should Know

April 4, 2018